ALPL antibody (AA 52-150) (FITC)
Quick Overview for ALPL antibody (AA 52-150) (FITC) (ABIN730995)
Target
See all ALPL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 52-150
-
Cross-Reactivity
- Human, Mouse
-
Predicted Reactivity
- Rat,Dog,Cow,Pig,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from AP-TNAP/ALPL
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- ALPL (Alkaline Phosphatase, Liver/bone/kidney (ALPL))
-
Alternative Name
- Ap-Tnap/Alpl
-
Background
-
Synonyms: Akp2, TNAP, Akp-2, APTNAP, TNSALP, Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, Alkaline phosphatase 2, Alkaline phosphatase liver/bone/kidney isozyme, Alpl
Background: Alkaline phosphatase (ALP) removes phosphate groups from the 5' end of DNA and RNA, and from proteins, at high pH . Most mammals have 4 different isozymes: placental, placental like, intestinal and non tissue specific (found in liver, kidney and bone). Tissues with particularly high concentrations of ALP include the liver, bile ducts, placenta, and bone. Damaged or diseased tissue releases enzymes into the blood, so serum ALP measurements can be abnormal in many conditions, including bone disease and liver disease.
-
Gene ID
- 11647
-
UniProt
- P09242
Target
-